Pfizer and BioNTech release safety and efficacy data from phase 2/3 trials for their COVID-19 mRNA vaccine.
Further research is needed to identify possible interventions that may mitigate the racial disparities seen in COVID-19.
Case of a 15-year-old African American girl with COVID-19 who developed atrial fibrillation and fulminant myocarditis.
Cutaneous and histopathologic manifestations of COVID-19 infection in a pediatric population are described.
The effect of HIV serostatus on brachial artery flow-mediated dilation strongly influenced by kidney function.
Investigators examined whether brensocatib reduces incidence of exacerbations of bronchiectasis, reduces rate of exacerbations, or changes the concentration of active neutrophil in the sputum from baseline.
Investigators assessed whether interleukin-6 inhibitors reduced the odds of in-hospital COVID-related mortality.
Researchers examined duration of viral RNA shedding and viable virus shedding of SARS-CoV-2 in body fluids and compared SARS-CoV-2, SARS-CoV, and MERS-CoV viral dynamics.
The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.
Study researchers investigated whether the COVID-19 pandemic potentially contributed to the delay in acute stroke care.
Investigators conducted the PlasmAr trial to evaluate the safety and efficacy of convalescent plasma in the treatment of SARS-CoV-2 pneumonia.
Investigators examined incidence, clearance, and risk factors for 13 high-risk human papilloma virus types in gay and bisexual men with HIV.
A case review demonstrates the challenges in differentiating interstitial lung disease from COVID-19 during the global pandemic.
The drug is designed to modulate the acute inflammatory response observed in patients with NSTI that leads to organ dysfunction or failure.
Investigators determined whether ABO and Rh blood groups were associated with risk for SARS-CoV-2 infection and severe COVID-19 illness.
Authors conducted a systematic review and meta-analysis to assess the impact of PDR on treatment outcomes among people initiating NNRTI-based ART.
Investigators explored the implications of updated vaccination strategies for typhoid fever targeting younger at-risk children in the United States.
The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube.
The test should be utilized in accordance with its Emergency Use Authorization and as described in the authorized labeling to reduce the risk of false negative results.
Investigators reported detailed microbiology, risk factors, and outcomes of secondary bloodstream infections in patients with severe COVID-19.